Context Therapeutics (CNTX) Non-Current Assets (2020 - 2026)
Context Therapeutics (CNTX) reported Non-Current Assets of $315,292 for Q2 2026, up 54.7% from $203,866 a year earlier but down 7.9% from the prior quarter.
Powered by 
Analysis
Context Therapeutics (CNTX) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Context Therapeutics posted Non-Current Assets of $140,066, down 39.3% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of -3.6% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $230,775 in FY2024, $15,524 in FY2023 (-86.2%), $112,285 in FY2022 (+122.8%) and $50,389 in FY2021 (-70.0%).
- Five-year quarterly Non-Current Assets spans a low of $10,388 in Q2 2024 and a high of $1.82 million in Q3 2021.
- Year over year, Non-Current Assets gained in two of the last four quarters, with growth averaging 6.9%.
- The high point for year-over-year Non-Current Assets in five years was Q4 2022 (growth of 122.8%); the low point was Q3 2022 (a decline of 92.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $342,277 (Q1 2026), $140,066 (Q4 2025) and $172,343 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.99 Bn | 1,104.58 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 616.90 Bn | 535.42 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 501.56 Bn | 474.68 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.13 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 236.48 Bn | 191.88 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 190.56 Bn | 164.76 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 169.46 Bn | 116.11 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Context Therapeutics | 21.80 Mn | -218.66 Mn | - | 315,292.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 315,292.00 |
| Mar 31, 2026 | 342,277.00 |
| Dec 31, 2025 | 140,066.00 |
| Sep 30, 2025 | 172,343.00 |
| Jun 30, 2025 | 203,866.00 |
| Mar 31, 2025 | 234,656.00 |
| Dec 31, 2024 | 230,775.00 |
| Sep 30, 2024 | 259,028.00 |
| Jun 30, 2024 | 10,388.00 |
| Mar 31, 2024 | 12,956.00 |
| Dec 31, 2023 | 15,524.00 |
| Sep 30, 2023 | 18,092.00 |
| Jun 30, 2023 | 52,703.00 |
| Mar 31, 2023 | 80,455.00 |
| Dec 31, 2022 | 112,285.00 |
| Sep 30, 2022 | 143,827.00 |
| Jun 30, 2022 | 196,956.00 |
| Mar 31, 2022 | 175,466.00 |
| Dec 31, 2021 | 50,389.00 |
| Sep 30, 2021 | 1.82 Mn |
API Access
Context Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=CNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "CNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=CNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();